212 related articles for article (PubMed ID: 31605148)
1. Phosphorylation-dependent regulation of the NOTCH1 intracellular domain by dual-specificity tyrosine-regulated kinase 2.
Morrugares R; Correa-Sáez A; Moreno R; Garrido-Rodríguez M; Muñoz E; de la Vega L; Calzado MA
Cell Mol Life Sci; 2020 Jul; 77(13):2621-2639. PubMed ID: 31605148
[TBL] [Abstract][Full Text] [Related]
2. FBXW7 tumor suppressor regulation by dualspecificity tyrosine-regulated kinase 2.
Jiménez-Izquierdo R; Morrugares R; Suanes-Cobos L; Correa-Sáez A; Garrido-Rodríguez M; Cerero-Tejero L; Khan OM; de la Luna S; Sancho R; Calzado MA
Cell Death Dis; 2023 Mar; 14(3):202. PubMed ID: 36934104
[TBL] [Abstract][Full Text] [Related]
3. Serum- and glucocorticoid-inducible kinase 1 (SGK1) controls Notch1 signaling by downregulation of protein stability through Fbw7 ubiquitin ligase.
Mo JS; Ann EJ; Yoon JH; Jung J; Choi YH; Kim HY; Ahn JS; Kim SM; Kim MY; Hong JA; Seo MS; Lang F; Choi EJ; Park HS
J Cell Sci; 2011 Jan; 124(Pt 1):100-12. PubMed ID: 21147854
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of DYRK2 in cancer.
Tandon V; de la Vega L; Banerjee S
J Biol Chem; 2021; 296():100233. PubMed ID: 33376136
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression.
Banerjee S; Wei T; Wang J; Lee JJ; Gutierrez HL; Chapman O; Wiley SE; Mayfield JE; Tandon V; Juarez EF; Chavez L; Liang R; Sah RL; Costello C; Mesirov JP; de la Vega L; Cooper KL; Dixon JE; Xiao J; Lei X
Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24881-24891. PubMed ID: 31754034
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Notch1 signaling by the APP intracellular domain facilitates degradation of the Notch1 intracellular domain and RBP-Jk.
Kim MY; Mo JS; Ann EJ; Yoon JH; Jung J; Choi YH; Kim SM; Kim HY; Ahn JS; Kim H; Kim K; Hoe HS; Park HS
J Cell Sci; 2011 Jun; 124(Pt 11):1831-43. PubMed ID: 21558417
[TBL] [Abstract][Full Text] [Related]
7. Stability of the human pregnane X receptor is regulated by E3 ligase UBR5 and serine/threonine kinase DYRK2.
Ong SS; Goktug AN; Elias A; Wu J; Saunders D; Chen T
Biochem J; 2014 Apr; 459(1):193-203. PubMed ID: 24438055
[TBL] [Abstract][Full Text] [Related]
8. Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases.
Correa-Sáez A; Jiménez-Izquierdo R; Garrido-Rodríguez M; Morrugares R; Muñoz E; Calzado MA
Cell Mol Life Sci; 2020 Dec; 77(23):4747-4763. PubMed ID: 32462403
[TBL] [Abstract][Full Text] [Related]
9. Integrin-linked kinase controls Notch1 signaling by down-regulation of protein stability through Fbw7 ubiquitin ligase.
Mo JS; Kim MY; Han SO; Kim IS; Ann EJ; Lee KS; Seo MS; Kim JY; Lee SC; Park JW; Choi EJ; Seong JY; Joe CO; Faessler R; Park HS
Mol Cell Biol; 2007 Aug; 27(15):5565-74. PubMed ID: 17526737
[TBL] [Abstract][Full Text] [Related]
10. Engagement of DYRK2 in proper control for cell division.
Nihira NT; Yoshida K
Cell Cycle; 2015; 14(6):802-7. PubMed ID: 25603354
[TBL] [Abstract][Full Text] [Related]
11. Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation.
Jung HY; Wang X; Jun S; Park JI
J Biol Chem; 2013 Mar; 288(10):7252-62. PubMed ID: 23362280
[TBL] [Abstract][Full Text] [Related]
12. Tumor Suppressor HIPK2 Regulates Malignant Growth via Phosphorylation of Notch1.
Ann EJ; Kim MY; Yoon JH; Ahn JS; Jo EH; Lee HJ; Lee HW; Kang HG; Choi DW; Chun KH; Lee JS; Choi CY; Ferrando AA; Lee K; Park HS
Cancer Res; 2016 Aug; 76(16):4728-40. PubMed ID: 27335110
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase.
Maddika S; Chen J
Nat Cell Biol; 2009 Apr; 11(4):409-19. PubMed ID: 19287380
[TBL] [Abstract][Full Text] [Related]
14. NOTCH1 intracellular domain negatively regulates PAK1 signaling pathway through direct interaction.
Yoon JH; Mo JS; Ann EJ; Ahn JS; Jo EH; Lee HJ; Hong SH; Kim MY; Kim EG; Lee K; Park HS
Biochim Biophys Acta; 2016 Feb; 1863(2):179-88. PubMed ID: 26547035
[TBL] [Abstract][Full Text] [Related]
15. Autophagy negatively regulates tumor cell proliferation through phosphorylation dependent degradation of the Notch1 intracellular domain.
Ahn JS; Ann EJ; Kim MY; Yoon JH; Lee HJ; Jo EH; Lee K; Lee JS; Park HS
Oncotarget; 2016 Nov; 7(48):79047-79063. PubMed ID: 27806347
[TBL] [Abstract][Full Text] [Related]
16. Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways.
Pérez M; García-Limones C; Zapico I; Marina A; Schmitz ML; Muñoz E; Calzado MA
J Mol Cell Biol; 2012 Oct; 4(5):316-30. PubMed ID: 22878263
[TBL] [Abstract][Full Text] [Related]
17. Multiple functions of DYRK2 in cancer and tissue development.
Yoshida S; Yoshida K
FEBS Lett; 2019 Nov; 593(21):2953-2965. PubMed ID: 31505048
[TBL] [Abstract][Full Text] [Related]
18. Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis.
Guo X; Wang X; Wang Z; Banerjee S; Yang J; Huang L; Dixon JE
Nat Cell Biol; 2016 Feb; 18(2):202-12. PubMed ID: 26655835
[TBL] [Abstract][Full Text] [Related]
19. Diminished DYRK2 sensitizes hormone receptor-positive breast cancer to everolimus by the escape from degrading mTOR.
Mimoto R; Nihira NT; Hirooka S; Takeyama H; Yoshida K
Cancer Lett; 2017 Jan; 384():27-38. PubMed ID: 27746162
[TBL] [Abstract][Full Text] [Related]
20. PLK1 targets NOTCH1 during DNA damage and mitotic progression.
De Blasio C; Zonfrilli A; Franchitto M; Mariano G; Cialfi S; Verma N; Checquolo S; Bellavia D; Palermo R; Benelli D; Screpanti I; Talora C
J Biol Chem; 2019 Nov; 294(47):17941-17950. PubMed ID: 31597699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
